Tickerplace logo

Tickerplace

Xeris Biopharma Holdings, Inc. logo

XERSXeris Biopharma Holdings, Inc.

XERS Stock Price, Valuation & Chart | Xeris Biopharma Holdings, Inc.

Compare
$8.580+0.15 (+1.78%)

At close · 02 Sept 2026, 08:00 pm

Sector: HealthcareIndustry: BiotechnologyXERS intrinsic valueXERS calculated fair value vs price
OverviewFinancialsDividendsRatios

XERS Historical price chart

XERS Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization1.48B
PE Ratio-80.56
EPS-0.11
Trading Volume1.35M
Today's High/Low8.63/8.27
Dividend Yield0.00
52 Week High/Low10.08/5.25
Shares Outstanding172.64M
XERS Financial Statement
XERS Analyst ratings
XERS Analysis & performance metrics

XERS Company profile

Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and…

XERS Management team

Management
Brian Conner
SVice President of Quality and Chief Compliance & Risk Officer
John P. ShannonCEO
Chief Executive Officer & Director
Allison Wey
Senior Vice President of Investor Relations & Corporate Communications
Steven M. PieperCFO
Chief Financial Officer
Paul R. Edick J.D.
Senior Advisor
Anh Nguyen M.B.A., M.D.
Chief Medical Officer
Kendal Korte
Senior Vice President of Human Resources
Beth P. Hecht J.D.
Chief Legal Officer & Corporate Secretary
Total 8 executives

XERS Frequently asked questions

What is Xeris Biopharma Holdings, Inc. (XERS) Stock Price?

Current stock price of Xeris Biopharma Holdings, Inc. (XERS) stock is $8.580. The stock price is +1.78% higher in the session. The intraday range can be seen from this page. Volume of Xeris Biopharma Holdings, Inc. (XERS) stock is 1.35M.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Xeris Biopharma Holdings, Inc. (XERS) stock price going up or down today?

The stock price of Xeris Biopharma Holdings, Inc. (XERS) can change with earnings, company news, and overall market sentiment. Xeris Biopharma Holdings, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Xeris Biopharma Holdings, Inc. stock expensive at its current price?

Whether Xeris Biopharma Holdings, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for XERS on this page is -80.56. EPS on this page is -0.11. Compare those figures with peers and growth expectations before deciding if the current Xeris Biopharma Holdings, Inc. price is justified.

How has the stock price of Xeris Biopharma Holdings, Inc. (XERS) performed historically?

Historical performance for Xeris Biopharma Holdings, Inc. (XERS) is shown on the price chart on this page. Review multi-period moves alongside volume to see how XERS reacted to past earnings and market events.

Should I buy Xeris Biopharma Holdings, Inc. (XERS) stock, at this price?

Buying Xeris Biopharma Holdings, Inc. (XERS) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.